55-year-old male with a smoldering myeloma screening for clinical trial. Multiplanar multisequence MRI of the pelvis was performed before and after administration of 18 cc's of intravenous Mulithance per the research protocol.
Multiplanar multisequence MRI of the pelvis was performed before and after administration of 18 cc's of intravenous Mulithance per the research protocol.